/ Medien
"Arbitrariness in health insurance decisions?"
![[Translate to English:] Logo Puls](/fileadmin/user_upload/dkf/Aktuelles/Sendung-Puls00.jpg?1572701281)
The SRF broadcast "PULS" on latest findings by the study team of PD Dr. Lars Hemkens (Senior Scientist Clinical Epidemiology/DKF) and PD Dr. Benjamin Kasenda (Hematology, Oncology/USB). (in German)
About a quarter of all cancer drugs are prescribed off-label. The Basel study team presents first results from their study "Reimbursement reality for off-label use in cancer care" which document a problem that needs to be addressed.